Hyloris Partner Signs To Market Maxigesic IV In Central And Eastern Europe
Hyloris Has Also In-Licensed A Blood Mineral Deficiency Drug
Hyloris’ partner AFT has signed an exclusive licensing and distribution agreement with Salus Pharmaceuticals covering nine central and eastern European countries. Meanwhile, Hyloris has also struck an in-licensing deal for a new blood phosphorus deficiency treatment.
